22.5.14

212 / To Nicolas Sarkozy / July 11, 2009 / France


On Saturday, July 11, 2009 12:25 PM, bagher mohammadpour <bmp1337@yahoo.com> wrote:


B. Mohammad pour,
Paris, France.


Date: 04.07.2009 

The Right Honorable Nicolas Sarkozy
The President of France Republic

Abut two weeks ago or more I sent you a letter on a National Disaster in the pharmaceutical industries of iran. That letter was written a long time before the post-election events.
Unfortunately bloody recent events in Iran put the final and absolute proof on my belief in
the first page of that letter that:  

The government uses all his power
 against his subjects
no less than against external enemies.

and
IN IRAN
the struggle between Liberty and Authority
has never been so harsh and bloody
during the last century.




 
Below you find MHRA (Engish body) belief on the legal status of that crisis. For known reasons, MHRA did not expresse its detailed opinions on the subject but French experts in Ministry of Health are able to provide you more information and I believe their opinions are the best proof on all my claims stated in my letter.

I hope to receive very soon the support of you country in favor of a nation who
are living the darkest period of their history in the last century.

Respectfully yours
B Mohammadpour


RE: An Incredable Report From....a little pharmacist
MHRA Information Centre <info@mhra.gsi.gov.uk>
To:bmp1337@yahoo.com
 Dear  Mr B Mohammad pour,

Manufacturing sites in the UK and sites in countries that manufacture product for the UK are regularly
inspected to ensure compliance to the  EU Good Manufacturing Practice Guidelines (GMP).
If a site fails to meet applicable GMP standard then their license to manufacture pharmaceuticals can
be varied or revoked.

  
If a site continues to manufacture (ie manufactures without a license and hence illegally) then Enforcement
powers exist such that individuals  in the UK can be prosecuted under the Medicines Act.
The penalties applicable in such cases are  2 years imprisonment and/or unlimited fine.


 We can not comment on what  should or does happens in non EU countries if
Good Manufacturing Practice is not adhered to.. 

 Your sincerely

B J Wright Group Manager Inspection
Medicines and Healthcare products Regulatory Agency Tel: 020 7084 2000

 



No comments:

Post a Comment